#ovarian cancer

Squelching Ovarian Cancer: The Not-So-Silent Killer

A nationwide shortage of cancer drugs is causing thousands of patients to experience delays in treatment.

Fred Hutch researchers examined risks and health outcomes for Black and white women with endometriosis and fibroids.

Chemotherapy drugs are increasingly in short supply, warn the American Cancer Society and ACS CAN about this life-threatening situation.

More than a third of people with predisposition genes for breast, ovarian or colon cancer would not have qualified for genetic screening.

People who consumed highly processed food had a greater risk for ovarian and brain cancers and higher cancer mortality.

Newly FDA-approved drugs for ovarian, bladder, liver cancer, and more.

Results of the SORAYA study show antibody-drug conjugate produced remissions in one-third of patients with drug-resistant ovarian cancer.

Advances in immunotherapy, new drug approvals and news about hard-to-treat cancers caught readers’ attention this year.

Elahere, a new antibody-drug conjugate, shrank tumors in about a third of treatment-experienced patients.

Black patients with ovarian cancer were less likely than their white counterparts to be treated according to NCCN guidelines.

Music teacher Winona Williams lives a life not dominated by her ovarian cancer diagnosis—and she hopes her treatment will help others.

September is Gynecologic Cancer Awareness Month.

September is Ovarian Cancer Awareness Month

The combination of target drugs Tafinlar-Mekinist is approved for nearly any type of advanced solid tumor that has the BRAF gene mutation.

A nutritionist who believes in the power of food and yoga to nourish the mind and body of cancer survivors

Becoming a patient advocate during her mom’s ovarian cancer journey led to her life’s work to improve the cancer experience.